diabetic foot ulcer

Original Research

Treatment of Hard-to-heal Diabetic Foot Ulcers With a Hepatic-derived Wound Matrix

09/02/2020

Robert Fridman

Payam Rafat

Carl C. Van Gils

Deena Horn

Dean Vayser

C. Jake Lambert, Jr

This study evaluates the ability of a novel hepatic-derived wound matrix to treat hard-to-heal diabetic foot ulcers.

This study evaluates the ability...

09/02/2020

Wounds

Clinical Cases

Evaluating the Safety and Efficacy of an Advanced Wound Care Matrix in the Management of Nonhealing DFUs

03/19/2020

This 10-patient case series demonstrates the efficacy and safety of an advanced wound matrix featuring a bilayer structure that is specifically designed for the management of chronic wounds in the treatment of diabetic foot ulcers.

This 10-patient case series...

03/19/2020

Wounds

Case Report and Brief Review

Combining the Benefits of Collagen and Negative Pressure Wound Therapy to Heal a Chronic Diabetic Foot Ulcer: A Case Report

03/17/2020

Jeffrey D. Lehrman

This report is on the use of a collagen wound contact layer in conjunction with negative pressure wound therapy to achieve healing in a chronic diabetic foot ulcer.

This report is on the use of a...

03/17/2020

Wounds

Original Research

Human-derived Acellular Dermal Matrix Grafts for Treatment of Diabetic Foot Ulcers: A Systematic Review and Meta-analysis

02/01/2020

Margaret Luthringer

Thayer Mukherjee

Marvin Argüello-Angarita

Mark S. Granick

Oscar M. Alvarez

This meta-analysis compares human-derived acellular dermal matrices (H-ADMs) with standard of care (SOC) to evaluate the number of healed ulcers at 12 and 16 weeks and number of days to complete healing. As a secondary outcome, the efficacy...

This meta-analysis compares...

02/01/2020

Wounds

Case Series

Clinical Efficacy of Acellular Dermal Matrix Paste in Treating Diabetic Foot Ulcers

02/01/2020

Myungchul Lee

Dongkeun Jun

Hyungon Choi

Jeenam Kim

Donghyeok Shin

In this study, the authors evaluate the efficacy of applying a paste formulation of acellular dermal matrix (ADM) to DFUs.

In this study, the authors...

02/01/2020

Wounds

Case Series

Use of a Remote Temperature Monitoring Mat for the Early Identification of Foot Ulcers

02/01/2020

Jaminelli L. Banks

Brian J. Petersen

Gary M. Rothenberg

Annie S. Jong

Jeffrey C. Page

This article presents a case series supporting the use of RTM for early identification of DFUs.

This article presents a case...

02/01/2020

Wounds

Case Series

Use of Oxidized Regenerated Cellulose (ORC)/Collagen/Silver-ORC Dressings Alone or Subsequent to Advanced Wound Therapies in Complex Wounds

02/01/2020

Robert J. Klein

This article examines the use of ORC/collagen/silver-ORC dressings alone or subsequent to advanced wound therapies in a retrospective cohort of 24 patients.

This article examines the use of...

02/01/2020

Wounds

Rapid Communication

Comparative Effectiveness of Two Collagen-containing Dressings: Oxidized Regenerated Cellulose (ORC)/Collagen/Silver-ORC Dressing Versus Ovine Collagen Extracellular Matrix

11/30/2019

Leah Griffin

Marissa J. Carter

Ralph D’Agostino

Lucy D’Agostino McGowan

This comparative effectiveness study evaluates the value proposition of 2 collagen-containing wound dressings — oxidized regenerated cellulose (ORC)/collagen/silver-ORC dressing and ovine collagen extracellular matrix (ECM) — in matched...

This comparative effectiveness...

11/30/2019

Wounds

Clinical Cases

Health Care Resource Utilization of Patients With Stage 3 and 4 PUs and DFUs Treated Early With CCO

11/13/2019

This study estimates health care resource utilization in the early initiation of clostridial collagenase ointment vs late initiation of clostridial collagenase ointment in stage 3 and 4 pressure ulcers and diabetic foot ulcers in the United...

This study estimates health care...

11/13/2019

Wounds

Comparative Effectiveness of a Human Fibroblast-derived Dermal Substitute versus a Fetal Bovine Collagen Dressing for the Treatment of Diabetic Foot Ulcers in a Real-world Setting

Background: This was a retrospective comparative effectiveness research (CER) study to evaluate the clinical outcomes of a human fibroblast-derived dermal substitute (HFDS) and a fet...

08/19/2019